Cushing Asset Management, LP Abiomed Inc Transaction History

Cushing Asset Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $184,586 - $228,008	-614 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $8,995 - $10,909	-29 Reduced 4.51%	614 $200,000
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $621,571 - $830,868	-2,366 Reduced 78.63%	643 $201,000
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $103,217 - $128,201	361 Added 13.63%	3,009 $959,000
Q3 2020 Nov 16, 2020	BUY	$255.22 - $317.0 $84,988 - $105,561	333 Added 14.38%	2,648 $734,000
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $189,900 - $345,271	-1,343 Reduced 36.71%	2,315 $559,000
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $309,439 - $464,739	2,371 Added 184.23%	3,658 $531,000
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $7,646 - $10,729	48 Added 3.87%	1,287 $220,000
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $217,927 - $345,965	1,239 New	1,239 $220,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Cushing Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cushing Asset Management, LP with notifications on news.